1. Home
  2. SELX vs LPTX Comparison

SELX vs LPTX Comparison

Compare SELX & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SELX
  • LPTX
  • Stock Information
  • Founded
  • SELX 2021
  • LPTX 2011
  • Country
  • SELX Taiwan
  • LPTX United States
  • Employees
  • SELX N/A
  • LPTX N/A
  • Industry
  • SELX
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SELX
  • LPTX Health Care
  • Exchange
  • SELX Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • SELX 34.0M
  • LPTX 35.4M
  • IPO Year
  • SELX N/A
  • LPTX N/A
  • Fundamental
  • Price
  • SELX $0.80
  • LPTX $0.49
  • Analyst Decision
  • SELX
  • LPTX Hold
  • Analyst Count
  • SELX 0
  • LPTX 1
  • Target Price
  • SELX N/A
  • LPTX N/A
  • AVG Volume (30 Days)
  • SELX 25.3K
  • LPTX 7.7M
  • Earning Date
  • SELX 01-01-0001
  • LPTX 11-12-2025
  • Dividend Yield
  • SELX N/A
  • LPTX N/A
  • EPS Growth
  • SELX N/A
  • LPTX N/A
  • EPS
  • SELX N/A
  • LPTX N/A
  • Revenue
  • SELX $1,040,571.00
  • LPTX N/A
  • Revenue This Year
  • SELX N/A
  • LPTX N/A
  • Revenue Next Year
  • SELX N/A
  • LPTX N/A
  • P/E Ratio
  • SELX N/A
  • LPTX N/A
  • Revenue Growth
  • SELX N/A
  • LPTX N/A
  • 52 Week Low
  • SELX $0.76
  • LPTX $0.22
  • 52 Week High
  • SELX $1.86
  • LPTX $4.79
  • Technical
  • Relative Strength Index (RSI)
  • SELX 34.54
  • LPTX 48.97
  • Support Level
  • SELX $0.80
  • LPTX $0.43
  • Resistance Level
  • SELX $0.95
  • LPTX $0.50
  • Average True Range (ATR)
  • SELX 0.10
  • LPTX 0.07
  • MACD
  • SELX -0.00
  • LPTX -0.03
  • Stochastic Oscillator
  • SELX 14.39
  • LPTX 16.33

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.

Share on Social Networks: